Rheumatology Masters: The Ultimate Quiz Show on the Science of Biosimilars
Carrie Beach, BSN, RN-BC
Staff Rheumatology Nurse
Columbus Arthritis Center
Teri Puhalsky, BSN, RN, CRNI
Medstar Orthopaedic Institute
This activity has been designed to meet the educational needs of rheumatology nurses, nurse practitioners, and physician assistants. Other healthcare providers may also participate.
Learning Objective and Goal:
Upon completion of this activity, participants should be able to:
- Describe the U.S. Food and Drug Administration’s approval process for biosimilars, focusing on how and why it differs from the approval process for generic and biologic drugs
- Explain key concepts related to biosimilars such as drug interchangeability, substitution, and data extrapolation
- Analyze current barriers to the use of biosimilars in clinical practice
- Discuss the importance of patient education surrounding biosimilars and the appropriate role of the nurse and advanced practice provider as patient educator as part of the shared decision making process
Rheumatology Nurses Society is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500).
Rheumatology Nurses Society designates this educational activity for 0.75 contact hours.
According to the disclosure policy of RNS, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose all financial relationships with ineligible companies. The existence of these financial relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. All identified relevant financial relationships are mitigated.
Relationships are abbreviated as follows: E, Educational planning committee; G, Grant/research support recipient; A, Advisor/review panel member; C, Consultant; S, Stock shareholder; SB, Speaker bureau; PE, Promotional event talks; H, Honoraria; O, Other.
Disclosures are as follows:
Carrie Beach, BSN, RN-BC, has the following relevant financial relationship specific to the subject matter of the content included in this educational activity, which has been mitigated: Janssen/C; Aurinia/SB.
Teri Puhalsky, BSN, RN, CRNI, has no relevant financial relationships specific to the subject matter of the content of the activity.
Kim Cheramie, MSN, RN, NPDA-BC, Nurse Planner, Rheumatology Nurses Society, has no relevant financial relationships specific to the subject matter of the content of the activity.
Scott Kober, MBA, Managing Director, Excalibur Medical Education has no relevant financial relationships specific to the subject matter of the content of the activity.
Kristin Harper, PhD, MPH, ELS, Medical Writer, has no relevant financial relationships specific to the subject matter of the content of the activity.
Kevin Lyons, Executive Director of the Rheumatology Nurses Society and Chief Executive Officer of Lyons Den Solutions, LLC, has no relevant financial relationships specific to the subject matter of the content of the activity.
Off-Label Product Disclosure
This activity will not include a discussion of off-label or investigational use of products.
Method of Participation
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CNE contact hours for your participation, please complete the activity (achieving a passing grade of 225 points or greater), and program evaluation. Your certificate can be printed immediately.
This activity is supported by an educational grant from Pfizer.